Status:
COMPLETED
Technology Assisted Stepped Collaborative Care Intervention
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of New Mexico
Conditions:
End-Stage Renal Disease
Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates a collaborative care intervention in reducing depression, fatigue and pain symptoms and improving health related quality of life in hemodialysis patients. Half of participants wil...
Detailed Description
End-stage renal disease patients on hemodialysis experience substantial symptom burden with fatigue, pain and depression among the most debilitating and existing as symptom clusters. These symptom clu...
Eligibility Criteria
Inclusion
- 18 years or older
- undergoing thrice-weekly maintenance hemodialysis for \> 3 months
- English speaking
- able to provide informed consent
- no evidence of thought disorder, delusions or active suicidal ideation
Exclusion
- thought disorder, delusions or active suicidal ideation
- active substance abuse
- too ill or cognitively impaired to participate based on clinicians' judgment
- anticipated life expectancy of less than 1 year
- unable or unwilling to adhere to study protocol
- participating in another clinical trial or taking an investigational drug
- scheduled for living donor kidney transplant within next 6 months
- relocating to another dialysis unit within 6 months
Key Trial Info
Start Date :
March 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03440853
Start Date
March 28 2018
End Date
June 30 2022
Last Update
July 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213